APA (7th ed.) Citation

Huttner, N. A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J. A., Büning, H., & Hallek, M. (2003). Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Therapy, 10(26), 2139. https://doi.org/10.1038/sj.gt.3302123

Chicago Style (17th ed.) Citation

Huttner, N. A., A. Girod, L. Perabo, D. Edbauer, J. A. Kleinschmidt, H. Büning, and M. Hallek. "Genetic Modifications of the Adeno-associated Virus Type 2 Capsid Reduce the Affinity and the Neutralizing Effects of Human Serum Antibodies." Gene Therapy 10, no. 26 (2003): 2139. https://doi.org/10.1038/sj.gt.3302123.

MLA (9th ed.) Citation

Huttner, N. A., et al. "Genetic Modifications of the Adeno-associated Virus Type 2 Capsid Reduce the Affinity and the Neutralizing Effects of Human Serum Antibodies." Gene Therapy, vol. 10, no. 26, 2003, p. 2139, https://doi.org/10.1038/sj.gt.3302123.